Pharmacyclics LLC, an AbbVie Company, and Janssen Biotech, Inc., partner to develop and commercialize IMBRUVICA® (ibrutinib) for oncology and other serious diseases in the United States.

Pharmacyclics LLC
1000 Gateway Blvd.
South San Francisco, CA 94080
Phone: 1-408-215-3000

Janssen Biotech, Inc.
800 Ridgeview Drive
Horsham, PA 19044

Medical Information Inquiries

For medical information about IMBRUVICA®, please contact the AbbVie Medical Information contact center number at 844-663-3742
To report a possible adverse event or product quality complaint, please call 800-633-9110.

To contact us by email, please fill out the form located here:

You are encouraged to report side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.